The Role of a Patent Attorney in the Life Sciences Sector In the rapidly evolving landscape of life sciences, the role of a patent attorney has never been more critical. …
Tag:
novartis
-
-
Breakthrough in Chronic Spontaneous Urticaria Treatment: EU Approves First Oral Targeted Therapy For the nearly 4 million adults in Europe living with chronic spontaneous urticaria (CSU), relief has often been …
-
Health
Coartem® (Artemether-Lumefantrine) Baby: First and Only Malaria Treatment for Newborns and Young Infants, Addressing a Critical Unmet Require
Coartem® (Artemether-Lumefantrine) for Infants and Young Children: A Critical Advance in Pediatric Malaria Treatment Malaria remains a leading cause of illness and death among children under five in sub-Saharan Africa, …
-
Novartis Settles Lawsuit with Henrietta Lacks’ Estate Over HeLa Cell Line Use In a landmark decision, Novartis has settled a lawsuit brought by the estate of Henrietta Lacks, resolving allegations …
-
Novartis’ Remibrutinib Shows Promise as First Targeted Therapy for Chronic Inducible Urticaria Basel, Switzerland – February 24, 2026 – Novartis announced positive results from its Phase III RemIND trial evaluating …
-
Pharmaceutical Companies to Lower Drug Prices for Medicaid Program Table of Contents Pharmaceutical Companies to Lower Drug Prices for Medicaid Program Details of the Agreement Impact and context Broader Implications …
-
“`html Chemical Engineering & Manufacturing Professional Chemical Engineering & Manufacturing Professional Table of Contents Chemical Engineering & Manufacturing Professional Work Experience Skills Core Engineering & Manufacturing Skills Quality & Compliance …
-
Shaping the Future of Medicine: The Evidence Generation Manager Role at Novartis At Novartis, a global leader in healthcare innovation, the future of medicine is being actively reimagined through the …
-
Novartis Announces Positive Phase III Results for Ianalumab in Primary Immune Thrombocytopenia (ITP) Table of Contents Novartis Announces Positive Phase III Results for Ianalumab in Primary Immune Thrombocytopenia (ITP) Ianalumab …